Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NNC0114-0006 and Liraglutide in Newly Diagnosed Type 1 Diabetes
NCT02443155Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Nov 2015
- Primary completion
- Aug 2018
- Modality
- Monoclonal Antibodies
- Countries
- 18
01
Overview
A Phase 2 trial of NNC0114-0000-0005 in type 1 diabetes mellitus (T1D), sponsored by Novo Nordisk. Started Nov 2015; status: completed.
02
Drugs
NNC0114-0000-0005
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02443155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02443155.